Kotak initiates coverage on Leela Hotels stock with Add rating

Kotak has initiated coverage on Schloss Bangalore Ltd (Leela Hotels) with an "Add" rating and a price target of INR475.00. The luxury hospitality company, operating 3,553 keys, is projected to achieve a 19% attributable EBITDA CAGR from FY2025-30E, driven by same-store RevPAR growth and planned additions of 763 owned and 203 managed keys. This positive outlook is underpinned by Leela's strong brand and limited luxury supply in key Indian cities, though Kotak identifies execution challenges, business cyclicality, and asset concentration as principal risks.

Analysis

Kotak has initiated coverage on Schloss Bangalore Ltd (Leela Hotels, THELEELA:IN) with a constructive 'Add' rating and an INR 475.00 price target. The thesis is predicated on a projected 19% compound annual growth rate (CAGR) in attributable EBITDA for the period FY2025-30E. This growth is expected to be fueled by a dual strategy of organic, same-store RevPAR increases and a significant expansion of its portfolio, adding 763 owned and 203 managed keys to its current base of 3,553. The company's strong brand equity and a constrained supply pipeline for luxury hotels in key Indian metropolitan areas are cited as key tailwinds. However, Kotak also flags material risks to this outlook, including execution challenges on its expansion projects, the hospitality sector's inherent business cyclicality, and asset concentration. The article's quality is questionable as it concludes with unrelated promotional content referencing a different ticker, SCHL, which should be disregarded in the context of the Leela Hotels analysis.

Key Decisions for Investors

• Investors with a bullish view on Indian luxury hospitality could view Kotak's 'Add' rating and projected 19% EBITDA CAGR as a strong entry point thesis for Schloss Bangalore Ltd.
• It is critical to monitor execution risk associated with the planned addition of nearly 1,000 keys and to remain cognizant of the sector's sensitivity to macroeconomic cycles.
• Given the poor quality of the source article, which conflates its analysis with promotional material for an unrelated ticker, investors should seek the original Kotak research note to validate the investment thesis and details before making any capital allocation decisions.